* Corresponding author. Mailing address: University of Washington, Department of Bioengineering, Box 355061, Seattle, WA 98195. Tel: (206) 685.8148. Fax: (206) 685. ...

Introduction Duloxetine has previously been reported to be promising in the setting of chemotherapy-induced peripheral neuropathy (CIPN). The aim of this study was to conduct a comprehensive ...

Oncologists vary widely in treating DLBCL with cardiomyopathy, often diverging from guidelines due to limited evidence on ...